Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a common anxiety drug and melatonin lift depression after brain injury?

NCT ID NCT04400266

First seen May 22, 2026 · Last updated May 22, 2026

Summary

This study tests whether a combination of buspirone (an anxiety medication) and melatonin (a sleep aid) can help with depression and thinking problems after a traumatic brain injury. Ten adults with mild or moderate brain injury who are still depressed will take the combination for several weeks. Researchers will measure mood, thinking skills, and brain scans to see if the treatment works and how it affects the brain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02144, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Massachusetts General Hospital Home Base Program

    RECRUITING

    Charlestown, Massachusetts, 02129, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.